Related Experiment Video

Updated: Aug 11, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Rho GTPases: promising cellular targets for novel anticancer drugs

Gerhard Fritz1, Bernd Kaina

  • 1Department of Toxicology, University of Mainz, Obere Zahlbacher Str. 67, D-55131 Mainz, Germany. fritz@uni-mainz.de

Current Cancer Drug Targets
|February 16, 2006
PubMed

Insights

Ras GTPases are crucial in cancer development and metastasis. Inhibiting their function, particularly through targeting Rho-kinase, shows promise for novel anticancer therapies and improving existing treatments.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Ras-homologous (Rho) GTPases regulate critical cellular processes including actin organization, motility, adhesion, cell cycle, gene expression, and apoptosis.
  • These functions are vital for cancer development, progression, and metastasis.
  • Rho GTPases are frequently overexpressed in malignancies and influence cellular responses to DNA damaging agents and antineoplastic drugs.

Purpose of the Study:

  • To explore the role of Rho GTPases in cancer and their potential as therapeutic targets.
  • To review experimental strategies for inhibiting Rho GTPase activity, focusing on isoprenylation inhibition and specific effector targeting.
  • To evaluate the therapeutic implications of modulating Rho GTPase pathways in cancer treatment.

Main Methods:

  • Review of existing literature on Rho GTPase function in cancer.
  • Analysis of experimental approaches targeting Rho GTPase isoprenylation (e.g., FTIs, GGTIs, statins).
  • Discussion of the development and efficacy of specific Rho GTPase inhibitors, such as Rho-kinase (ROK) inhibitors.

Main Results:

  • Inhibitors of Rho GTPase isoprenylation (FTIs, GGTIs, statins) have shown effects on tumor progression and therapeutic outcomes.
  • A significant drawback of isoprenylation inhibitors is their lack of selectivity for individual Rho GTPases.
  • Specific inhibitors targeting individual Rho GTPase functions, like Rho-kinase inhibitors, demonstrate anti-metastatic activity in vivo.

Conclusions:

  • Rho GTPases are promising targets for novel anticancer drug development due to their pleiotropic roles in cancer.
  • Targeting Rho GTPase isoprenylation can impact tumor progression and therapeutic responses, but selectivity remains a challenge.
  • Development of specific inhibitors, particularly for Rho-kinase, offers a promising strategy for anti-metastatic therapy and potentially enhancing conventional treatments.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...